NEW YORK (AP) — Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure. The New York company said ...

A federal advisory panel unanimously recommended approval Tuesday of a new drug to treat hepatitis B, putting Gilead Sciences on track to launch its second medicine in a year. The U.S. Food & Drug ...

There's a new drug regimen being touted as a potential cure for a dangerous liver virus that causes hepatitis C. But it costs $84,000 -- or $1,000 a pill. And that price tag is prompting outrage from ...

Hepatitis C virus (HCV) reinfection rates among people who inject drugs are high immediately after treatment in community settings, particularly among those reporting recent injection drug use and ...

(Reuters) - New York state Attorney General Eric Schneiderman's office has asked 16 health insurers for documentation on patients who have been denied coverage of drugs used to cure hepatitis C, a ...

On World Hepatitis Day today, the spotlight is on one of the most misunderstood but critical public health challenges, viral hepatitis. Observed annually on July 28, this global awareness day focuses ...

As with other drugs, Vosevi (sofosbuvir/velpatasvir/voxilaprevir) can cause side effects such as headache and diarrhea. If you’re not able to tolerate side effects ...

PORTLAND, Ore. (KOIN) – A new report from the Centers for Disease Control and Prevention shows Oregon has some of the worst hepatitis C rates in the nation, the Oregon Health Authority announced ...